Time Stamps
1:58 Merrick Smela's Early Influence
03:36 Ovelle's Founding: Travis Potter and Merrick Smela
05:07 Travis Potter's Motivation After Facing Fertility Struggles
06:44 Underfunding of IVG
07:48 Finance/Biotech Commonalities
09:15 Scientific Co-founder Role: Merrick Smela
09:56 Using Statistics in Design
12:25 Definition of IVG
12:54 Ovelle's Mission to Revolutionize Infertility Treatment
13:33 IVG vs. IVF
15:49 Ovelle's Unique Scientific Approach
16:39 Direct Activation vs. Natural Signaling:
18:17 Meiosis Paper Innovation: Identifying Regulatory Factors that can Activate Meiosis from Stem Cells
21:23 Team Building: Finding Dedicated Scientists
24:20 Culture Difference (Meaning vs. Money)
28:35 IVG Process Overview:
29:36 IVM is Achieved in Humans:
30:35 Quality Control and Safety of Eggs
32:35 Prioritization using Critical Path Analysis:
35:02 Investor Funding for IVG as a New Fertility Approach
41:21 Rapid Fire Questions
